Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Guaranteed Paid Placement
    • Cision Media Monitoring
    • Multichannel Amplification
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Multichannel Amplification
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • Cision Media Monitoring
  • Cision IR
  • SocialBoost
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

YSG's first participation at WCD, with two major brands
  • USA - English


News provided by

Yatsen Global

28 Jul, 2023, 13:09 CST

Share this article

Share toX

Share this article

Share toX

SINGAPORE, July 28, 2023 /PRNewswire/ -- In recent years, along with the iterative innovation of beauty science and technology, the growth of Chinese beauty industry has been gaining the attention of the international market. The 25th World Congress of Dermatology (hereinafter referred to as WCD), known as "the Olympic of dermatology", was held in Singapore from July 3 to 8. Yatesn Holding limited(YSG)for the first time as official sponsor with its skincare brands, DR. WU and Galénic, and became one of the few China domestic cosmetic enterprises in this grand international event.

Continue Reading
YSG at WCD (PRNewsfoto/Yatsen Global)
YSG at WCD (PRNewsfoto/Yatsen Global)
Galénic at WCD (PRNewsfoto/Yatsen Global)
Galénic at WCD (PRNewsfoto/Yatsen Global)

WCD, the international dermatology conference held every four years, is the world's longest history conference and one of the most influential academic events in the field of dermatology. This year's WCD attracted more than 12,000 renowned experts and scholars, representatives of dermatology, industry leaders, and representatives of enterprises from more than 180 countries and regions around the world to gather in Singapore.

At the congress, YSG not only delivered the Innovative achievements in dermatology, such as VC ActiveAnchor™ Technology and nanoencapsulated sustained-release technology, but also shared the new solutions in the field of anti-aging and medical skincare, such as Super Retinoids of step-by-step anti-aging solutions, multi-dimensional anti-aging by regulating on both the endogenous and exogenous factors, etc. The innovative ideas of beauty technology have been approached and approved by many dermatologists and professors from all over the world.  

First time at "Olympic of dermatology", YSG showing up with multiple R&D achievements

As the theme of the Congress, "Dermatology Beyond Borders", YSG is commited to break through the boundaries, jointly with numbers of scientific research institutes, laboratories, universities and hospitals around the world in order to serve segmented skincare needs of Chinese and global customers, to carry out industry-university-academy-medicine cooperation, and devoted to building a powerful moat for the sustainable development of enterprises with the open innovation system — Open Lab.

Based on the Open Lab R&D system, YSG has successfully transformed a series of exclusive proprietary technological achievements in recent years, which have gone through clinical trials in hospitals to ensure the safety and effectiveness of the products, such as TransHealer, vitis vinifera stem cell extract, PATENTED ALGAE-TIDE* and so on. During WCD, these innovative achievements and various on-site products experience halted overseas visitors for more information.

In recent years, YSG has continued to increase its investment in R&D. In 2022, the Company upgraded its annual R&D expense ratio to 3.4%, which continued to be in the front rank globally. By the end of 2022, YSG has submitted 174 patent applications worldwide,, among which 43 are invention patents (some of them are in assignment of patent).

YSG's participation in WCD will be an important step in the layout of its global R&D system. YSG will keep leading the new development of the beauty and health industry by grasping the world's cutting-edge scientific research intelligence and concepts and the global trends of medical skincare, and seeking common development with global dermatology experts.

Relying on the core advantage of the Group's global R&D resources, its brands DR. WU and Galénic have also exploited and found out innovative paths integrating industry, universities, academies and medicine.

20 years of Dermetologists developed, DR. WU takes clinical research achievements to the international stage

This year marks the 20th anniversary of DR. WU. While exhibiting its remarkable dual clinical study at the WCD, it is also celebrating the brand's 20th anniversary in Singapore.

Prof. Yen Loo LIM, Secretary General of WCD, addressed the 20th anniversary ceremony, "It is great to see a brand like DR. WU providing big impetus to the original development of dermatology", and hoped that DR. WU would keep contributing to dermatology research and development in Asia and the world.

At the 20th anniversary celebration, Prof. Zhizhong ZHENG, Chairman of DR. WU's Brand Expert Committee, an authoritative leader in the field of acne, the first president of Chinese Dermatologist Association (branch of Chinese Medical Doctor Association), launched a joint initiative to advocate that "efficacy-based skincare needs to follow evidence-based therapy and return to ultimate user value of building healthy skin". The initiative was supported by Secretary General of WCD, Prof. Yen Loo LIM, CEO of YSG, Mr. Jinfeng Huang, and other guests.

On the day of the event, DR. WU also invited Prof. Qiang Ju, an outstanding dermatologist at home and abroad to share the latest advances in acne diagnosis and treatment and clinical research on Mandelic Mutiple acid, and brought two new products— the new members of the Mandelic famliy, "DR.WU Mendelik Purifying Renewal Essence Toner", and DR. WU's first professional 3A retinol anti-aging essence "DR.WU Tri-Retinoid Intensive Revitalizing Serum".

In recent years, DR. WU has continued to consolidate the power of dermatology, empowering the co-created and developed products of clinical practice and research, and launched Multiple Acid Renewal Mask and Gel, Triple Action Repair Series, etc. Among them, DR. WU's Triple-Action Repair Serum applies the exclusive proprietary formula "TransHealer"— nanoencapsulated sodium heparin and other four active ingredients, which can provide precise solutions to red post-acne marks and redness repair. Relevant results have been published in the world peer-reviewed journal Molecules and indexed by SCI, one of the world's top three scientific and technical literature retrieval systems. DR. WU thus became one of the few Chinese beauty brands with papers included in SCI.

Focused on the Functional Ingredients,  Galénic's 45-year devotion to in-depth research on ActiveAnchor(TM)Technology

As a cutting-edge brand that combines medical practise with skincare application, Galénic was invited to this year's WCD. Over the years, Galénic has not only been highly recognized by the International League of Dermatological Societies (ILDS), but also, since its birth over the past 45 years, has been active in the world's major events with the technology pillars of the industry's high-standard scientific researches of and academic resources.

One of the highlights of this year's WCD is Galénic's launch of its PATENTED ALGAE-TIDE* and VC ActiveAnchor™ Technology.

The PATENTED ALGAE-TIDE*, an exclusive ingredient that has taken more than 20 years of research, is the latest achievement of Galénic in the field of anti-aging. The scientific combination of snow algae essence and its exclusive Rheolique, which is applied in the third generation of Couture Secret D'excellence Active Cream, can accurately solve the problem of skin aging, demonstrating Galénic's professionalism in dermatological research.

Besides the PATENTED ALGAE-TIDE*, Galenic golden-3 principles of VC have also gained high attentions from dermatological professionals around the world, and its product GALENICEUTICALS [N°1]BRIGHTENING RADIANCE ENERGY SERUM has been recognized and praised by many customers.

The five-day trip at WCD has injected new vitality and elements into YSG's product upgrading and technological development. The Company will take this exhibition as a good opportunity to link academic organizations, medical institutions and related industry experts and other resources to provide consumers with better products, and contribute to dermatology with the wisdom and strength of Chinese enterprises.

SOURCE Yatsen Global

Modal title

Contact Cision

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2025 Cision US Inc.